medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2008, Number 1

<< Back Next >>

Acta Pediatr Mex 2008; 29 (1)

Neural tube defects. Epidemiologic situation in Mexico (I of II)

Mancebo-Hernández A, González-Rivera A, Díaz-Omaña L, López-Alquicira M, Domínguez-Viveros W, Serrano-Sierra A

Language: Spanish
References: 24
Page: 41-47
PDF size: 215.18 Kb.


ABSTRACT

Neural tube defects (NTD) are a group of malformations resulting from abnormal closure of the neural tube owing to genetic and environmental factors interactions. The main NTD are cleft spine, which includes meningocele, myelomeningocele and anencephalia. The purpose of Epidemiologic Surveillance System of Neural Tube Defects is to unify criteria for their surveillance with timely and qualified management. Impact and importance of NTD is readily apparent in the high costs which include hospitalization, medication, etc. and in the other hand the emotional effect on patients and their families. These costs can not be met by most families nor by health services. All of this has a negative social and economic effect on the families. This review presents the current situation of the NTD surveillance. Proposals to implement preventive, diagnostic and therapeutic measures for NTD are recommended.


REFERENCES

  1. SSA/ CENAVECE/ Manual de Procedimientos para la Vigilancia Epidemiológica de los Defectos del Tubo Neural, México.2005.

  2. Tellerías L. Defectos de Cierre del Tubo Neural. Unidad Genética Servicio de Pediatría.Fa. Med. Universidad de Chile. Año 3, No. 4, Edición Mayo 2003.

  3. MMWR, 1991;40(30):513-16 CDC. Use of folic acid for prevention of spina bifida and other neural tube defects 1983-1991.

  4. Northup H, Volcik KA. Spina bifida and other neural tube defects. University of Texas, USA. Curr Probl Pediatr 2000;30:313-22.

  5. Padmanabhan R. Etiology, pathogenesis and prevention of neural tube defects. Congenit Anom (Kyoto) 2006;46(2):55-67.

  6. Parck CH, Stewart W, Khoury MJ, Mulinare J. Is there etiologic heterogeneity between upper and lower neural tube defects?. Am J Epidemiol 1992;136(12):1493-501.

  7. Frey L, Hauser WA. Epidemiology of neural tube defects.Epilepsia 2003;44(Suppl 3):4-13.

  8. Li Z, Ren A, Zhang L, Guo Z. A population-based case-control study of risk factors for neural tube defects in four high-prevalence areas of Shanxi province, China. Paediatr Perinat Epidemiol 2006;20(1):45-53.

  9. Shaw GM, Rozen R, Finell RH, Wasserman CR, Lammer EJ. Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida. Am J Epidemiol 1999;150(3):323-4.

  10. Li Z, Ren A, Zhang L, Ye R, Li S, Zheng J y cols. Extremely high prevalence of neural tube defects in 4-county areas in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol 2006;76(4):237-40.

  11. Canfield MA, Agnegers JF, Brender JD, Cooper SP, Greenberg F. Hispanic origin and neural tube defects in Houston/ Harris County, Texas. II. Risk factors. Am J Epidemiol 1996;143(1):12:24.

  12. Nevin NC, Johnston WP. Risk of recurrence after two children with central nervous system malformations in an area of high incidence. J Med Genet 1980;17(2):87-92.

  13. Stevenson RE, Allen WP, Pai GS, Best R y cols. Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics 2000;106(4):677-83.

  14. Joo JG, Beke A, Szigeti Z, Csaba A y cols. Craniospinal malformation in a twelve-year fetopathological study; the efficiency of ultrasonography in view of fetopathological investigation. Early Hum Dev 2007;174:823-89

  15. Laurence KM, Morris J. The effect of the introduction of prenatal diagnosis on the reproductive history of women at increased risk from neural tube defects. Prenat Diagn 1981;1(1):51-60.

  16. Martínez de Villareal LE, Arredondo P, Hernández R, Villareal JS.Weeky administration of folic acid and epidemiology of neural tube defects. Matern Child Health J. 2006;10(5):397-401.

  17. Kumar R, Singhal N. Outcome of meningomyelocele/lipomeningomyelocele in children of northern India. Pediatr Neurosurg.2007;43(1):7-14.

  18. CDC. Spina bifida and anencephaly before and after folic acid mandate-United States,1995-1996 and1999-2000. Morb Mortal Wkly Rep 2004;53(17):362-5.

  19. National Birth Defect Prevention Network. Congenital Malformations Surveillance Report. Teratology 1997;56(1/2):116–75.

  20. Smithells RW, Sheppard S, Schorah CJ, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980;1:339-40.

  21. Elwood JM, Little J, Elwood JH. Epidemiology and Control of Neural Tube Defects. New York. Oxford University Press 1992.

  22. Centers for Disease Control and Prevention: Prevalence of spina bifida at birth – United States, 1983-1990: a comparison of two surveillance systems. MMWR 1998;45(No. SS-2):15-26.

  23. Baird PA. Neural tube defects in the Sikhs. Am J Med Genet 1983;16:49-56.

  24. Elwood JH. Major central nervous system malformations notified in Northern Ireland 1964-1968. Dev Med Child Neurol1972;14:731-9.




2020     |     www.medigraphic.com